Skip to main content
Springer Nature Link
Log in

Severe Heart Failure in the ICU

  • Conference paper
Yearbook of Intensive Care and Emergency Medicine 2005

Part of the book series: EN]Yearbook of Intensive Care and Emergency Medicine ((volume 2005))

  • 656 Accesses

  • 1 Citation

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hunt S, Baker D, Chin M, et al (2001) ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: Executive Summary. Circulation 104:2996–3007

    PubMed  Google Scholar 

  2. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007–2018

    Article  PubMed  Google Scholar 

  3. Wu A, Cody R (2003) Medical and surgical treatment of chronic heart failure. Curr Probl Cardiol 28:225–260

    Article  Google Scholar 

  4. Packer M (2001) Current role of beta-adrenergic blockers in the management of chronic heart failure. Am J Med 110:81S–84S

    Article  PubMed  Google Scholar 

  5. Rose E, Gelijns A, Moskowitz A, et al (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435–1443

    PubMed  Google Scholar 

  6. Chin M, Goldman L (1996) Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med 156:1814–1820

    Article  PubMed  Google Scholar 

  7. Hochman J, Sleeper L, Webb J, et al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625–634

    Article  PubMed  Google Scholar 

  8. Jain P, Massie B, Gattis W, et al (2003) Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. Am Heart J 145:S3–S17

    Article  PubMed  Google Scholar 

  9. Steimle A, Stevenson L, Chelimsky-Fallick C, et al (1997) Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 96:1165–1172

    PubMed  Google Scholar 

  10. BHAT Trial Research Group (1982) A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 747:1707–1714

    Google Scholar 

  11. BHAT Trial Research Group (1983) A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. JAMA 250:2814–2819

    Google Scholar 

  12. CIBIS II Investigators (1999) The Cardiac Insufficiency Bisoprolol Study II: A randomized trial. Lancet 353:9–13

    Google Scholar 

  13. The MERIT-HF Study Group (2000) Effects of controlled release metoprolol on total mortality, hospitalizations and well-being in patients with heart failure. JAMA 283:1295–1302

    Google Scholar 

  14. The CAPRICORN Investigators (2001) Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: The CAPRICORN Randomized Trial. Lancet 357:1385–1390

    Google Scholar 

  15. Packer M, Coats A, Fowler M, et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658

    Article  PubMed  Google Scholar 

  16. Krum H, Roecker E, Mohacsi P, et al (2003) Effects on initiating carvedilol in patients with severe chronic heart failure. Results from the COPERNICUS Study. JAMA 289:712–718

    Article  PubMed  Google Scholar 

  17. Bristow M, Gilbert E, Abraham W, et al (1996) Carvedilol produces dose related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94:2807–2816

    PubMed  Google Scholar 

  18. Pfeffer M, Braunwald E, Moye L, et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327:669–677

    PubMed  Google Scholar 

  19. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685–691

    Google Scholar 

  20. Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273:1450–1456

    Article  PubMed  Google Scholar 

  21. The RESOLVD Pilot Study Investigators (1999) Comparison of candesartan, enalapril, and their combination in congestive heart failure. Circulation 100:1056–1064

    Google Scholar 

  22. Pitt B, Poole-Wilson P, Segal R, et al (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomized trial — The Losartan Heart Failure Survival Study (ELITE II). Lancet 355:1582–1587

    Article  PubMed  Google Scholar 

  23. Cohn J, Tognoni G (2001) A randomized trial of the angiotensin receptor blocker valsartan in chronic heart failure. N Engl J Med 345:1667–1675

    Article  PubMed  Google Scholar 

  24. Granger C, McMurray J, Yusuf S, et al (2003) Effects of candesartan patients with chronic heart failure and reduced left ventricular systolic function intolerant to angiotensin-converting enzyme inhibitors. The CHARM Alternate Trial. Lancet 362:772–776

    Article  PubMed  Google Scholar 

  25. McMurray J, Ostergren J, Swedberg K, et al (2003) Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function taking angiotensin-converting enzyme inhibitors. The CHARM — Added Trial. Lancet 362:759–766

    Article  PubMed  Google Scholar 

  26. Manohair P, Pina I (2003) Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure. Mayo Clinic Proc 78:334–338

    Google Scholar 

  27. Sharma D, Buyse M, Pitt B, et al (2000) Meta-Analysis of observed mortality data from all controlled double-blind multiple dose studies of losartan in heart failure. Am J Cardiol 85:187–192

    Article  PubMed  Google Scholar 

  28. Pitt B, Zannad F, Remme W, et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709–717

    Article  PubMed  Google Scholar 

  29. Pitt B, Remme W, Zannad F, et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321

    Article  PubMed  Google Scholar 

  30. The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336:525–533

    Google Scholar 

  31. Cohn J, Archibald D, Ziesche S, et al (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veteran's Administration Cooperative Study. N Engl J Med 314:1547–1552

    PubMed  Google Scholar 

  32. Publication Committee for the VMAC Investigators (2002) Intravenous nesiritide versus nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 287:1531–1540

    Google Scholar 

  33. Poole-Wilson P (2002) Treatment of acute heart failure: Out with the old, in the new. JAMA 287:1578–1580

    Article  PubMed  Google Scholar 

  34. Dormans T, Van-Meyel, J, Gerlag, P, et al (1996) Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 28:376–382.

    Article  PubMed  Google Scholar 

  35. Burger A, Horton D, LeGemtel T, et al (2002) Effect of neseritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT Study. Am Heart J 144:1102–1108

    Article  PubMed  Google Scholar 

  36. Chattergee K, DeMarco T (2003) Role of nonglycosidic inotropic agents: Indications, ethics, and limitations. Med Clin N Am 87:391–418

    Article  PubMed  Google Scholar 

  37. Colucci W, Elkayam U, Horton D, et al (2002) Intravenous nesiritide, a natriuetic in the treatment of decompensated congestive heart failure. N Engl J Med 343:246–253

    Article  Google Scholar 

  38. Leier C, Binkley P (1998) Parenteral inotropic support for advanced congestive heart failure. Prog Cardiovasc Dis 41:207–224

    Article  PubMed  Google Scholar 

  39. Stevenson L (2003) Clinical use of inotropic therapy for heart failure: Looking backward or forward? Part I: Inotropic infusions during hospitalization. Circulation 108:367–372

    Article  PubMed  Google Scholar 

  40. Stevenson L (1999) Tailored therapy for hemodynamic goals for advanced heart failure. Eur J Heart Fail 1:251–257

    Article  PubMed  Google Scholar 

  41. Stevenson L, Tillisch J (1986) Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation 74:1303–1308

    PubMed  Google Scholar 

  42. Colucci W, Wright R, Jaski B, et al (1986) Milrinone and dobutamine in severe heart failure: Differing hemodynamic effects and individual patient responsiveness. Circulation 73:175–183

    Google Scholar 

  43. Jaski B, Fifer M, Wright R, et al (1985) Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. J Clin Invest 75:643–649

    PubMed  Google Scholar 

  44. Shah M, Hasselblad V, Stinnett S, et al (2001) Hemodynamic profiles of advanced heart failure: Association with clinical characteristics and long-term outcomes. J Card Fail 7:105–113

    Article  PubMed  Google Scholar 

  45. Cuffe M, Califf R, Adams K, et al (2002) Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized control trial. JAMA 287:1541–1547

    Article  PubMed  Google Scholar 

  46. Abraham W, Adams K, Fonarow G, et al (2003) Comparison of in-hospital mortality in patients treated with neseritide versus other parenteral vasoactive medications for acutely decompensated heart failure: An analysis from a large prospective registry database. J Card Fail 2003; 9:S81 (abst)

    Article  Google Scholar 

  47. Silver M, Horton D, Ghali J, et al (2002) Effect of neseritide versus dobutamine on short-term outcomes in the treatment of patients with acute decompensated heart failure. J Am Coll Cardiol 39:798–803

    Article  PubMed  Google Scholar 

  48. OʻConnor C, Gattis W, Uretsky B, et al (1999) Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 138:78–86

    PubMed  Google Scholar 

  49. Packer M, Carver JR, Rodeheffer RJ, et al (1991) Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325:1468–1475

    PubMed  Google Scholar 

  50. Stevenson L (2003) Clinical use of inotropic therapy for heart failure: Looking backward or forward? Part II: Chronic inotropic therapy. Circulation 108:492–497

    Article  PubMed  Google Scholar 

  51. Feldman A, McNamara D (2000) Myocarditis. N Engl J Med 19:1388–1398

    Article  Google Scholar 

  52. Parrillo J (2001) Inflammatory cardiomyopathy (myocarditis) which patients should be treated with anti-inflammatory therapy. Circulation 104:4–6

    PubMed  Google Scholar 

  53. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45

    PubMed  Google Scholar 

  54. The Cardiac Arrhythmia Suppression Trial Investigators (1989) Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406–412

    Google Scholar 

  55. Singh S, Fletcher R, Fisher S, et al (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 333:77–82

    Article  PubMed  Google Scholar 

  56. Julian D, Camm A, Frangin G, et al (1997) Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349:667–674

    Article  PubMed  Google Scholar 

  57. The AVID Investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583

    Google Scholar 

  58. Connolly S, Gent M, Roberts R, et al (2000) Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297–1302

    PubMed  Google Scholar 

  59. Kuck K, Cappato R, Siebels J, et al (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 102:748–754

    PubMed  Google Scholar 

  60. MADIT Investigators (1995) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940

    Google Scholar 

  61. Buxton A, Lee, K, Fisher J, et al (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890

    Article  PubMed  Google Scholar 

  62. MADIT II Investigators (2001) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Google Scholar 

  63. Abraham W, Fisher W, Smith A, et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853

    Article  PubMed  Google Scholar 

  64. Bradley D, Bradley E, Baughman K, et al (2003) Cardiac resynchronization and death from progressive heart failure. A meta analysis of randomized control trials. JAMA 289:730–740

    Article  PubMed  Google Scholar 

  65. Young J, Abraham W, Smith A, et al (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD Trial. JAMA 289:2685–2694

    Article  PubMed  Google Scholar 

  66. Salukhe T, Francis D, Sutton R (2003) Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pace-maker-defibrillators reduce all cause mortality and hospitalization. Int J Cardiol 87:119–120

    Article  PubMed  Google Scholar 

  67. Goldstein G, Oz M, Rose E (1998) Medical progress: Implantable left ventricular assist devices. N Engl J Med 339:1522–1533

    Article  PubMed  Google Scholar 

  68. Nemeh H, Smedira N (2003) Mechanical treatment of heart failure: The growing role of LVADs and artificial hearts. Cleve Clin J Med 70:223–234

    PubMed  Google Scholar 

  69. Muller J, Wallukat G, Weng Y, et al (1997) Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96:542–549

    PubMed  Google Scholar 

  70. Prystowsky E (2000) Screening and therapy for patients with nonsustained ventricular tachycardia. Am J Cardiol 86(Suppl):34k–39k

    Article  Google Scholar 

Download references

Authors
  1. F. Ginsberg
    View author publications

    Search author on:PubMed Google Scholar

  2. J.E. Parrillo
    View author publications

    Search author on:PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ginsberg, F., Parrillo, J. (2005). Severe Heart Failure in the ICU. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2005. EN]Yearbook of Intensive Care and Emergency Medicine, vol 2005. Springer, New York, NY. https://doi.org/10.1007/0-387-26272-5_19

Download citation

  • DOI: https://doi.org/10.1007/0-387-26272-5_19

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-3-540-23476-0

  • Online ISBN: 978-0-387-26272-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Morty Proxy This is a proxified and sanitized view of the page, visit original site.